To assess the relevance of ACLY inhibition in human MASH-HCC, we first analysed the microarray dataset15 (GSE164760), comparing tumour, non-tumour adjacent, MASH, cirrhotic and healthy liver tissue. Here, ACLY is linked to hepatocellular carcinoma.